Good morning and welcome to Insider Finance. I’m Dan DeFrancesco, and here’s what’s on the agenda today:
- Citizens Bank’s CEO explains how a digital strategy will be key to growing the regional bank into a national brand.
- Raymond James’ top banker is keen to build out the boutique investment bank’s healthcare group a midst a surge in biotech deals.
- T. Rowe Price is eyeing the $7 trillion private-investing space.
Citizens Bank is in a ‘mad experimentation period’ to grow into a national powerhouse after buying HSBC’s US biz
We spoke with Citizens Bank CEO Bruce Van Saun, who detailed the regional bank’s digital strategy for branching out.
Raymond James’ investment-bank president wants to double the healthcare group’s revenue in 3 years as biotech remains hot
Raymond James’ top banker, Jim Bunn, explained why biotech is the key to the firm’s growth in healthcare. Here’s how he plans to capitalize on the hot biotech market.
Chris Newman, head of the Americas for T. Rowe Price’s institutional business, spoke with Insider about the $1.6 trillion asset manager’s push into alternative investments, like private credit. Take an inside look at the firm’s strategy.
The firm is acquiring Nutmeg, a UK digital wealth manager with some £3.5 billion in assets. More on that here.
Managing director Michael O’Leary walked Insider through how the fund thinks about activism. Here’s what he said.
Mark T. Gallogly, a Centerbridge Partners cofounder, is a special advisor to Biden’s climate envoy. Find out more about the appointment.